BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37074508)

  • 1. Body mass index increases the risk of breast cancer-related lymphedema at 6-18 months after surgery: a retrospective study.
    Wang L; Chen H; Li Y; Wang H; Liu N; Yu M; Shang S
    Support Care Cancer; 2023 Apr; 31(5):278. PubMed ID: 37074508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study.
    Jia M; Pan L; Yang H; Gao J; Guo F
    Breast Cancer Res Treat; 2024 Apr; 204(2):223-235. PubMed ID: 38097882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time trend of breast cancer-related lymphedema according to body mass index.
    Ogiya A; Kimura K; Ueno T; Iwase T; Ohno S
    Eur J Surg Oncol; 2024 Jun; 50(6):108350. PubMed ID: 38653160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
    Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
    Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the Risk Factors of Breast Cancer-Related Lymphedema and Construction and Evaluation of a Prediction Model.
    Li H; Li WB; Sun ZX; Yu J; Lv PY; Li CX; Liang X; Yu Y; Zhao ZB
    Lymphat Res Biol; 2023 Dec; 21(6):565-573. PubMed ID: 37768813
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients.
    Zheng SY; Chen CY; Qi WX; Cai G; Xu C; Cai R; Qian XF; Shen KW; Cao L; Chen JY
    Breast; 2023 Apr; 68():142-148. PubMed ID: 36764019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of combined risk factors on breast cancer-related lymphedema: a study using decision trees.
    Jinbo K; Fujita T; Kasahara R; Jinbo R; Kisara S; Onobe J; Kimijima I; Yasuda M; Yamamoto Y
    Breast Cancer; 2023 Jul; 30(4):685-688. PubMed ID: 36917351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of bioelectrical impedance analysis for detection of lymphedema in breast Cancer survivors: a prospective cross sectional study.
    Lim SM; Han Y; Kim SI; Park HS
    BMC Cancer; 2019 Jul; 19(1):669. PubMed ID: 31286884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer-Related Lymphedema.
    Montagna G; Zhang J; Sevilimedu V; Charyn J; Abbate K; Gomez EA; Mehrara B; Morrow M; Barrio AV
    JAMA Oncol; 2022 Aug; 8(8):1195-1200. PubMed ID: 35679026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.
    Nguyen TT; Hoskin TL; Habermann EB; Cheville AL; Boughey JC
    Ann Surg Oncol; 2017 Oct; 24(10):2972-2980. PubMed ID: 28766228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and Clinical Utility of Prediction Models for Breast Cancer-Related Lymphedema Incorporating Racial Differences in Disease Incidence.
    Rochlin DH; Barrio AV; McLaughlin S; Van Zee KJ; Woods JF; Dayan JH; Coriddi MR; McGrath LA; Bloomfield EA; Boe L; Mehrara BJ
    JAMA Surg; 2023 Sep; 158(9):954-964. PubMed ID: 37436762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.
    Naoum GE; Roberts S; Brunelle CL; Shui AM; Salama L; Daniell K; Gillespie T; Bucci L; Smith BL; Ho AY; Taghian AG
    J Clin Oncol; 2020 Oct; 38(29):3430-3438. PubMed ID: 32730184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
    Helyer LK; Varnic M; Le LW; Leong W; McCready D
    Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration.
    Aoishi Y; Oura S; Nishiguchi H; Hirai Y; Miyasaka M; Kawaji M; Shima A; Nishimura Y
    Breast Cancer; 2020 Sep; 27(5):929-937. PubMed ID: 32270417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
    McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
    J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Bioimpedance Spectroscopy with Risk Factors for the Development of Breast Cancer-Related Lymphedema.
    Vicini F; Shah C; Whitworth P; Walker M; Shi J
    Lymphat Res Biol; 2018 Dec; 16(6):533-537. PubMed ID: 30133336
    [No Abstract]   [Full Text] [Related]  

  • 17. Patients who report cording after breast cancer surgery are at higher risk of lymphedema: Results from a large prospective screening cohort.
    Brunelle CL; Roberts SA; Shui AM; Gillespie TC; Daniell KM; Naoum GE; Taghian A
    J Surg Oncol; 2020 Aug; 122(2):155-163. PubMed ID: 32497273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and Feasibility of an Immediate Lymphatic Reconstruction Program in a Community Health System.
    Haravu PN; Shakir A; Jackson K; Alva D; Feldman J; Sisco M; Seth AK
    Ann Surg Oncol; 2024 Jan; 31(1):672-680. PubMed ID: 37938474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and predictors of axillary web syndrome and its association with lymphedema in women following breast cancer treatment: a retrospective study.
    Ryans K; Davies CC; Gaw G; Lambe C; Henninge M; VanHoose L
    Support Care Cancer; 2020 Dec; 28(12):5881-5888. PubMed ID: 32270312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast Cancer.
    Herremans KM; Cribbin MP; Riner AN; Neal DW; Hollen TL; Clevenger P; Munoz D; Blewett S; Giap F; Okunieff PG; Mendenhall NP; Bradley JA; Mendenhall WM; Mailhot-Vega RB; Brooks E; Daily KC; Heldermon CD; Marshall JK; Hanna MW; Leyngold MM; Virk SS; Shaw CM; Spiguel LR
    Ann Surg Oncol; 2021 Oct; 28(10):5775-5787. PubMed ID: 34365563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.